Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
FDA approval · 2023-03-07FDA Approved: GEMCITABINE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic gemcitabine under an Original Application (ANDA). This marks the approval of a generic…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma [Phase 4]
A Phase 4 clinical trial is evaluating disitamab vedotin in combination with gemcitabine as neoadjuvant therapy for urothelial carcinoma und…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine [Phase 1, Phase 2]
Clinical trial update on Catumaxomab for non-muscle-invasive bladder cancer in patients who failed or are intolerant to BCG, spanning Phase …
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of GEN1044 (DuoBody-CD3x5T4) in malignant solid tumors has been terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab [Phase 2]
A Phase 2 neoadjuvant trial assessing pembrolizumab monotherapy in muscle-invasive bladder cancer to study mechanisms of action.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer [Phase 2]
Phase 2 trial update evaluating response to two induction courses (12 intravesical instillations) of BCG for high-risk superficial bladder c…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) [Phase 2]
Phase 2 trial evaluating IPI-549 in combination with nivolumab for advanced urothelial carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 clinical trial update for Everolimus (RAD001) in metastatic transitional cell carcinoma of the urothelium (bladder cancer) completed…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC [Phase 2]
A Phase 2 trial compared neoadjuvant chemotherapy to surgery alone in patients with high-grade upper tract urothelial carcinoma, completed.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) [Phase 2]
Phase 2 BAYOU trial evaluating durvalumab alone and in combination with olaparib for advanced platinum-ineligible bladder cancer; results we…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer [Phase 2]
Phase 2 trial evaluating atezolizumab given concurrently with radiotherapy in patients with muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 trial update evaluating pembrolizumab in combination with intravesical BCG solution for recurrent non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Tranexamic Acid During Cystectomy Trial (TACT) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating tranexamic acid during cystectomy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating an oncolytic adenovirus in combination with a PD-1 inhibitor for non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer [Phase 2]
Phase 2 trial updating pembrolizumab as maintenance therapy after initial chemotherapy in metastatic bladder cancer; study completed with re…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma [Phase 4]
Phase 4 clinical study evaluating disitamab vedotin with penpulimab as neoadjuvant therapy for HER2-expressing cisplatin-intolerant bladder …
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2b study of UGN-102 for low-grade, intermediate-risk non-muscle-invasive bladder cancer has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery [Phase 3]
Phase 3 clinical trial update exploring multicenter preventive antibiotics with cystectomy within enhanced recovery after surgery for bladde…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 trial evaluating CV301 in combination with PD-1/PD-L1 blockade in locally advanced or metastatic bladder cancer has completed with p…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of radiation therapy and chemotherapy for Stage I bladder cancer. Conducted by the Radiati…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Clinical trial update for avelumab plus BCG in non-muscle invasive bladder cancer (Phase 1/2) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors [Phase 2]
Phase 2 trial exploring DPX-Survivac with low-dose cyclophosphamide and pembrolizumab in selected advanced solid tumors; currently active/no…